U.S. Mortgage REITs Stock News

In January 2026, Alcoa Corporation reported strong fourth-quarter and full-year 2025 results, with higher sales of US$12,831 million and net income of US$1,170 million, alongside increased aluminum production and guidance for further output growth in 2026. Beyond the headline earnings beat, Alcoa highlighted record production at multiple smelters, progress restarting the San Ciprián facility, and plans to monetize idle sites, all while advancing low-carbon technologies such as the ELYSIS...

Earlier this week, Elastic announced the general availability of Agent Builder and the tech preview of Elastic Workflows, tools that let developers rapidly create secure, context-driven AI agents and automate actions across enterprise systems on Elastic Cloud Serverless and other Elastic Cloud tiers. By combining context-rich search with rule-based orchestration, Elastic is positioning its platform as a foundation for moving AI projects from experimentation into production-grade automation...

Seagate Technology Holdings (STX) is back in focus after major banks raised their expectations and several institutions expanded their positions. This shift comes alongside the company’s AI focused storage showcase at Intersec 2026. See our latest analysis for Seagate Technology Holdings. The latest AI focused product showcase and rising institutional interest have arrived alongside firm share price momentum, with a 21.32% 1 month share price return, 47.83% 3 month share price return, and a...

McEwen (NYSE:MUX) reported a 23% year over year increase in Indicated gold resources at its Grey Fox Project. The company plans to fold recent property acquisitions, including the Stroud Property, into the next phase of Grey Fox development. New high grade drill results and an accelerated underground mining approach are set to inform the updated project plan. For investors tracking McEwen, the Grey Fox update comes on the heels of a sharp share price move, with NYSE:MUX up 17.3% over the...

What Just Happened With Valmont Industries (VMI)? Valmont Industries (VMI) has been drawing fresh attention after its recent share price performance, with the stock showing mixed short term moves but positive returns over the past month and past 3 months. See our latest analysis for Valmont Industries. At around $440 per share, Valmont Industries has seen a modest pullback in the last week, while its 1 month and year to date share price returns remain positive and its 1 year total...

Sky Constant Century (SKYC) has recently reshaped its board by adding Mr. Zhiqing Lu and Mr. Huibin Jiang. The company links these appointments to sharpening governance as it assesses future business opportunities and potential new directions. See our latest analysis for Sky Constant Century. The recent board changes come as the share price has moved sharply, with a 1 day share price return of 58.56% and a very large 90 day share price return. However, the 3 year and 5 year total shareholder...

Chinese regulators have escalated their investigation into PDD Holdings (NasdaqGS:PDD), sending more than 100 investigators to the company’s headquarters. The probe focuses on alleged fraudulent deliveries and tax compliance issues, following a physical altercation between PDD employees and officials. Authorities have issued fines, PDD has dismissed staff involved in the incident, and operations have experienced delays in marketing and project timelines. Multiple law firms have launched...

If you are wondering whether Assurant at around US$233 per share still offers value, you are not alone. The stock’s current price invites a closer look at what you are actually paying for. The share price closed at US$233.39, with returns of a 0.3% decline over 7 days, a 3.5% decline over 30 days and a 1.8% decline year to date, while the 1 year and 3 year returns stand at 12.4% and 88.5% respectively, and the 5 year return is 87.9%. Recent price moves sit against a backdrop of ongoing...

Palantir Technologies (PLTR) is back in focus after two major commercial wins: an expanded multi year alliance with HD Hyundai in Korea and a role in new sovereign AI data centers across EMEA, ahead of its upcoming earnings. See our latest analysis for Palantir Technologies. Despite the HD Hyundai expansion and the new sovereign AI role, Palantir's 30 day share price return of 12.65% and 90 day share price return of 8.14% indicate fading near term momentum. At the same time, the 1 year total...

In January 2026, Establishment Labs Holdings Inc. reported preliminary unaudited revenue guidance for the fourth quarter of 2025 of US$64.0 million to US$65.0 million, including US$17.0 million to US$17.5 million from Motiva sales in the United States. For full-year 2025, the company expects US$210.5 million to US$211.5 million in revenue, with Motiva’s United States contribution highlighting the growing importance of that market within its overall sales mix. We’ll examine how this...

Recent performance snapshot Vita Coco Company (COCO) has drawn fresh attention after a strong past 3 months, with a total return of about 31.9% and a 1 year total return of roughly 35.3%. That share move sits alongside reported annual revenue of US$609.3 million and net income of US$69.2 million, with both revenue and net income growth figures reported at 10.2% and 20.0% respectively. See our latest analysis for Vita Coco Company. Vita Coco’s share price has been choppy in the short term,...

In January 2026, Prestige Consumer Healthcare’s TheraTears brand announced two new nationwide products, Eyelid Cleansing Wipes and Dry & Tired preservative-free lubricant eye drops, aimed at gentle daily lid care and relief from screen-related eye fatigue. The launches underscore how Prestige is tailoring its eye-care portfolio to everyday digital device use, with individually wrapped wipes and single-use vials designed for convenience and sensitive eyes. With these new TheraTears offerings...

SentinelOne, Inc. recently confirmed that Chief Growth Officer Barry Padgett formally assumed the role of interim Chief Financial Officer and principal financial officer on January 16, 2026, following the previously announced resignation of CFO Barbara Larson. This leadership transition arrives after a period of investor unease around growth, guidance, and profitability, putting extra focus on how the finance function supports SentinelOne’s evolving business priorities. We’ll now examine how...

If you are wondering whether WesBanco's current share price offers good value or not, the key question is how that price compares with what the business might reasonably be worth. With the stock last closing at US$34.67 and returns of 0.8% over 7 days, 1.3% over 30 days, 4.0% year to date, 6.3% over 1 year, 11.0% over 3 years, and 49.0% over 5 years, many investors are asking whether the recent performance still leaves room for attractive value or instead signals a change in risk. Recent...

Recent performance snapshot for Home Bancshares stock Home Bancshares (HOMB) shares recently closed at $28.35, with a modest loss over the past year despite positive total returns over the past 3 years and 5 years, which may interest longer term investors. Shorter term moves have been mixed, with a 1 day return of about a 3.3% decline, a 7 day return of roughly a 2% decline, and a small loss over the past month. Over the past 3 months the shares show a mid single digit gain. In this context,...

Q2 Holdings (QTWO) is back in focus after quarterly results topped analyst estimates for revenue and EBITDA, and management raised full year EBITDA guidance, prompting investors to reassess the digital banking specialist’s stock. See our latest analysis for Q2 Holdings. The quarterly beat and guidance upgrade come after a mixed share price run. A 9.99% 90 day share price return contrasts with a 27.26% 1 year total shareholder return decline and a 108.65% 3 year total shareholder return gain,...

In January 2026, Manas AI announced a multi-year agreement granting it extensive access to Schrödinger’s physics-based computational drug discovery platform and expert support, aimed at integrating this technology with its AI “world model” for identifying diverse molecular binders. A key angle for investors is that Schrödinger’s tools will be tightly embedded into Manas AI’s large-scale discovery workflows, potentially reinforcing Schrödinger’s position in AI-enabled molecular design...

Why Fresh Del Monte Produce Is Back in Focus Fresh Del Monte Produce (FDP) is back on investors’ radar after reports of several years of stagnant sales and a forecasted 2.9% revenue decline, raising fresh questions about demand and the company’s growth options. See our latest analysis for Fresh Del Monte Produce. Against concerns about softer demand, Fresh Del Monte Produce’s share price has moved to $38.12, with a 30 day share price return of 5.98% and a 90 day gain of 10.91%. Its 1 year...

In recent weeks, ImmunityBio has reported updated Phase 2 data in recurrent glioblastoma, advanced FDA discussions on its ANKTIVA bladder cancer filings, and secured Saudi approvals for ANKTIVA in both non-muscle invasive bladder cancer and metastatic non-small cell lung cancer. Together, these developments highlight ImmunityBio’s attempt to build a broad immunotherapy platform spanning checkpoint-experienced lung cancer, bladder cancer, and chemo-free cell therapy combinations in...

In recent months, Barrington Research has repeatedly reaffirmed its “Outperform” rating on Grand Canyon Education, underscoring confidence in the company’s business performance amid sector headwinds and regulatory uncertainties. At the same time, Riverwater Partners highlighted Grand Canyon Education as a major short-term detractor while still describing it as a high-quality operator with resilient demand and strong returns on invested capital. Next, we’ll examine how this combination of...

Oruka Therapeutics, Inc. recently reported positive interim data from its first-in-human Phase 1 trial of ORKA-002, showing a long half-life, sustained IL-17 inhibition and a class-consistent safety profile in healthy volunteers, while outlining multiple ongoing and planned psoriasis and hidradenitis suppurativa studies across its ORKA-001 and ORKA-002 programs. A key insight for investors is the early clinical evidence suggesting ORKA-002 may enable twice-yearly maintenance dosing,...

Recent analyst commentary around Expedia Group (EXPE) has centered on rising confidence in its tech driven model, with upgraded stock recommendations and higher published targets following progress in B2B, the One Key rollout, and share buybacks. See our latest analysis for Expedia Group. At a share price of US$271.14, Expedia Group has seen a 23.89% 90 day share price return and a 59.63% 1 year total shareholder return, suggesting recent momentum after a softer past month. If this shift in...

In late 2025 and early 2026, United Bankshares completed a US$27.37 million buyback of 700,000 shares, or about 0.5% of its stock, while reporting fourth-quarter 2025 earnings and revenue that exceeded Wall Street expectations and delivered strong year-on-year sales growth. The combination of record 2025 earnings, benefits from the Piedmont Bancorp acquisition, and active share repurchases underscored solid capital strength and cash generation alongside better-than-expected quarterly...

Waystar Holding (WAY) has put its new agentic intelligence capabilities for its AltitudeAI platform in the spotlight, targeting more automated healthcare revenue workflows, just as it prepares for presentations at key industry conferences. See our latest analysis for Waystar Holding. Despite the recent product announcement and upcoming conference appearances, Waystar Holding's share price performance has been weak. The 30-day share price return shows a decline of 9.18%, the 90-day share price...